Our Recommendations
New Publications
- Strategic framework for the elimination of visceral leishmaniasis as a public health problem in eastern Africa 2023–2030 (2024)
- Global report on neglected tropical diseases 2023 (2023)
- Global leishmaniasis surveillance: 2021, assessing the impact of the COVID-19 pandemic (2022)
- Leishmaniasis is a vector-borne disease (2022)
- Community-Based Interventions for the Prevention and Control of Cutaneous Leishmaniasis (2022)
Filter
29
Featured
Language
Document type
Studies & Reports
26
Strategic & Response Plan
2
Fact sheets
1
Countries / Regions
Global
14
Latin America and the Carribbean
4
Kenya
2
Asia
2
Brazil
2
Sudan
2
Ethiopia
2
South Sudan
2
Somalia
2
India
2
Nepal
1
Turkey
1
China
1
Senegal
1
Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western and Central Europe
1
East and Southern Africa
1
Southern Africa
1
Bangladesh
1
Eastern Europe
1
Greece
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
11
Disease Prevention & Control
9
Health System Strengthening
2
Studies & Reports
2
Pharmacy & Technologies
2
Gender
1
Vector Control
1
NTDs & Others
1
Parasitology
1
Toolboxes
Leishmaniasis is a parasitic disease caused by the Leishmania parasite. This parasite typically lives in infected sand flies. You can contract leishmaniasis from a bite of an infected sand fly.
The sand flies that carry the parasite typically reside in tropical and subtropical environments. Fatal...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600...
More than one million people each year become infected by parasites that cause the disease cutaneous leishmaniasis (CL). This disease manifests as one or more skin lesions or ulcers that are slow to heal with variable response rates to drug treatments. Thus far, little attention has been paid to how...
Leishmaniasis is a spectrum of disease caused by the infection of protozoan parasite Leishmania mainly affecting the antigen presenting cell of the host. The disease is although considered as neglected tropical disease still it is not completely eradicated. Majority of the issues related to the ther...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
This article considers the current public health perspective on cutaneous leishmaniasis (CL) and its implications for incidence, prevalence, and global burden of disease calculations. CL is the most common form of leishmaniasis and one of a small number of infectious diseases increasing in incidence...
American cutaneous leishmaniasis (CL) is a severely understudied and neglected“disease of poverty” widespread throughout Peru. Transmission dynamics of CL are complex, requiring sandfly vectors and mammalian reservoir hosts to maintain the pathogen in a local environment whereby incidental hosts...
Leishmaniasis is a major vector-borne disease caused by obligate intramacrophage protozoa of the genus Leishmania, and transmitted by the bite of phlebotomine female sand flies of the genera Phlebotomus and Lutzomyia, in the old and new worlds, respectively. Among 20 well-recognized Leishmania speci...
Leishmaniasis is found in people in focal areas of approximately 90 countries in the tropics, subtropics, and southern Europe. The ecologic settings range from rain forests to deserts. Leishmaniasis usually is more common in rural than in urban areas, but it is found in the outskirts of some cities...
There is an urgent need to build Research and Development (R&D) capacity for leishmaniasis and other neglected tropical diseases (NTDs) in the Middle East and North Africa. The neglected tropical diseases are a group of 17 viral, bacterial, protozoan, and helminthic infections that often have high m...
The results of a large-scale systematic review and meta-analysis have published in PLOS Neglected Tropical Diseases. This research aimed to collate all reported serious adverse events (SAE) in visceral leishmaniasis (VL) clinical trials and quantify the incidence of mortality during the first 30 day...
Arab world’s growing contribution to global leishmaniasis research (1998–2017): a bibliometric study
Leishmaniasis is a parasitic disease caused by a protozoan of the Leishmania genus, and is considered a neglected tropical disease. It still remains a main public health concern at global level and in Arab world mainly in low-income countries. Therefore, this study was designed to evaluate the Arab ...
